X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2344) 2344
Publication (287) 287
Newspaper Article (46) 46
Book Review (24) 24
Book Chapter (16) 16
Dissertation (5) 5
Book / eBook (3) 3
Conference Proceeding (3) 3
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1387) 1387
index medicus (1266) 1266
chemokines (1188) 1188
male (855) 855
immunology (828) 828
female (805) 805
cytokines (794) 794
animals (787) 787
neurosciences (771) 771
inflammation (735) 735
cerebrospinal-fluid (722) 722
central-nervous-system (608) 608
adult (519) 519
middle aged (488) 488
mice (442) 442
research (441) 441
expression (383) 383
brain (380) 380
cerebrospinal fluid (374) 374
multiple sclerosis (373) 373
neurology (345) 345
proteins (326) 326
clinical neurology (314) 314
medicine (309) 309
research article (307) 307
aged (275) 275
infectious diseases (264) 264
experimental autoimmune encephalomyelitis (263) 263
disease (259) 259
chemokine (255) 255
health aspects (253) 253
multiple-sclerosis (250) 250
gene expression (237) 237
nervous system (231) 231
rodents (228) 228
multidisciplinary sciences (227) 227
pathogenesis (227) 227
science (227) 227
central nervous system (225) 225
cells, cultured (224) 224
chemokine receptors (221) 221
immune system (217) 217
lymphocytes (215) 215
analysis (212) 212
infections (211) 211
biomarkers (210) 210
cell biology (207) 207
monocyte chemoattractant protein-1 (204) 204
physiological aspects (202) 202
t-cells (202) 202
disease models, animal (195) 195
enzyme-linked immunosorbent assay (193) 193
mice, inbred c57bl (190) 190
microglia (186) 186
rats (185) 185
studies (183) 183
adolescent (171) 171
article (169) 169
immune response (168) 168
virology (166) 166
infection (165) 165
macrophages (165) 165
pathology (164) 164
genetic aspects (163) 163
blood-brain barrier (161) 161
hiv (158) 158
care and treatment (157) 157
cells (155) 155
necrosis-factor-alpha (152) 152
development and progression (151) 151
biology (150) 150
chemokines - metabolism (150) 150
flow cytometry (150) 150
activation (147) 147
blood-brain-barrier (147) 147
cytokines - metabolism (147) 147
risk factors (146) 146
biomarkers - cerebrospinal fluid (145) 145
diagnosis (145) 145
apoptosis (144) 144
cytokine (143) 143
neuroinflammation (143) 143
ligands (141) 141
young adult (141) 141
encephalitis (139) 139
dendritic cells (135) 135
child (132) 132
microbiology (132) 132
meningitis (131) 131
brain - pathology (130) 130
case-control studies (130) 130
patients (128) 128
lymphocytes t (125) 125
monocyte chemoattractant protein 1 (125) 125
t cells (125) 125
astrocytes (124) 124
neurons (123) 123
tumor-necrosis-factor (122) 122
medical research (118) 118
multiple sclerosis - immunology (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2382) 2382
German (8) 8
Polish (6) 6
Czech (3) 3
Japanese (3) 3
Portuguese (2) 2
Spanish (2) 2
Chinese (1) 1
Dutch (1) 1
French (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Neurology, ISSN 0364-5134, 03/2011, Volume 69, Issue 3, pp. 570 - 580
Journal Article
Brain, Behavior, and Immunity, ISSN 0889-1591, 10/2013, Volume 33, Issue Jul.,31, pp. 183 - 189
Neuroinflammation may be involved in the pathophysiology of Parkinson's disease (PD) and specifically in non-motor symptoms such as depression, fatigue and... 
C-reactive protein | Parkinson's disease | Cytokines | Depression | Fatigue | Neuroinflammation | Cerebrospinal fluid | Dementia | TREATMENT-RESISTANT DEPRESSION | ALZHEIMERS-DISEASE | MAJOR DEPRESSION | IMMUNOLOGY | FACTOR ANTAGONIST INFLIXIMAB | NEUROSCIENCES | NONMOTOR SYMPTOMS | TNF-ALPHA | DIAGNOSTIC-CRITERIA | BRAIN | Humans | Middle Aged | Fatigue - complications | Dementia - diagnosis | Male | Chemokine CCL26 | Chemokines, CC - cerebrospinal fluid | Chemokine CCL2 - cerebrospinal fluid | Inflammation Mediators - cerebrospinal fluid | Depression - cerebrospinal fluid | Parkinson Disease - cerebrospinal fluid | Dementia - cerebrospinal fluid | Depression - complications | Female | Interleukin-6 - cerebrospinal fluid | Cognition Disorders - cerebrospinal fluid | Parkinson Disease - complications | Chemokine CCL11 - cerebrospinal fluid | Chemokine CCL3 - cerebrospinal fluid | Tumor Necrosis Factor-alpha - cerebrospinal fluid | C-Reactive Protein - cerebrospinal fluid | Chemokine CCL4 - cerebrospinal fluid | Cognition Disorders - complications | Dementia - complications | Fatigue - cerebrospinal fluid | Parkinson Disease - diagnosis | Aged | Chemokine CCL24 - cerebrospinal fluid | Depression, Mental | Diagnosis | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 04/2010, Volume 27, Issue 4, pp. 669 - 682
There is an urgent need for both the scientific development and clinical validation of novel therapies for acute spinal cord injury (SCI). The scientific... 
Traumatic spinal cord injury | Biomarkers | Clinical trial | Inflammation | Cerebrospinal fluid | clinical trial | FUNCTIONAL RECOVERY | RAT | biomarkers | LEVEL NEUROPATHIC PAIN | TISSUE-DAMAGE | NEUROSCIENCES | CLINICAL NEUROLOGY | traumatic spinal cord injury | TUMOR-NECROSIS-FACTOR | inflammation | GM-CSF | cerebrospinal fluid | CLINICAL-TRIALS | CONTUSION INJURY | ICCP PANEL | DECREASES SECONDARY DEGENERATION | CRITICAL CARE MEDICINE | Predictive Value of Tests | Prospective Studies | Cytokines - analysis | Humans | Middle Aged | Interleukin-8 - cerebrospinal fluid | Male | Young Adult | Chemokine CCL2 - cerebrospinal fluid | Inflammation Mediators - cerebrospinal fluid | Inflammation Mediators - analysis | Myelitis - immunology | Recovery of Function - physiology | Nerve Growth Factors - cerebrospinal fluid | Interleukin-6 - cerebrospinal fluid | S100 Calcium Binding Protein beta Subunit | Myelitis - physiopathology | Biomarkers - analysis | Biomarkers - blood | Myelitis - cerebrospinal fluid | Trauma Severity Indices | Chemokine CCL2 - blood | Cytokines - cerebrospinal fluid | S100 Proteins - analysis | tau Proteins - blood | Spinal Cord - immunology | Spinal Cord - physiopathology | Biomarkers - cerebrospinal fluid | Chemokine CCL2 - analysis | Interleukin-6 - analysis | Prognosis | Spinal Cord - metabolism | Glial Fibrillary Acidic Protein - cerebrospinal fluid | Interleukin-6 - blood | S100 Proteins - blood | Adult | Female | Nerve Growth Factors - blood | Interleukin-8 - blood | Cytokines - blood | Enzyme-Linked Immunosorbent Assay | Glial Fibrillary Acidic Protein - analysis | S100 Proteins - cerebrospinal fluid | tau Proteins - cerebrospinal fluid | Interleukin-8 - analysis | Nerve Growth Factors - analysis | Glial Fibrillary Acidic Protein - blood | Spinal Cord Injuries - physiopathology | tau Proteins - analysis | Spinal Cord Injuries - diagnosis | Spinal Cord Injuries - cerebrospinal fluid | Care and treatment | Patient outcomes | Physiological aspects | Spinal cord injuries | Diagnosis | Biological markers | Cerebrospinal fluid proteins | Body fluids | Cytokines
Journal Article
Nature, ISSN 0028-0836, 02/2016, Volume 530, Issue 7590, pp. 349 - 353
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e61835
Background: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO), relapsing remitting multiple sclerosis (RRMS), and... 
RHEUMATOID-ARTHRITIS | CELLS | MESSENGER-RNA | MARKER | INFLAMMATION | MS | MULTIDISCIPLINARY SCIENCES | DISTINCT | T-HELPER TYPE-1 | DIAGNOSTIC-CRITERIA | SYNOVIAL-FLUIDS | Multiple Sclerosis, Chronic Progressive - cerebrospinal fluid | Recurrence | Aquaporin 4 - immunology | Chemokines - cerebrospinal fluid | Humans | Middle Aged | Male | Granulocyte-Macrophage Colony-Stimulating Factor - cerebrospinal fluid | Cytokines - cerebrospinal fluid | Interleukin-17 - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Adult | Female | Interleukin-6 - cerebrospinal fluid | Multiple Sclerosis, Relapsing-Remitting - cerebrospinal fluid | Development and progression | Neuromyelitis optica | Interleukins | T cells | Multiplexing | Neuroimaging | Immunoassay | Multiple sclerosis | Spinal cord | Disease | Carbon tetrachloride | Correlation coefficients | Interleukin | Central nervous system | Helper cells | Fluorescence | Lymphocytes T | Cerebrospinal fluid | Macrophages | Interleukin 6 | Proteins | Granulocyte colony-stimulating factor | Lymphocytes | Quality | Measurement methods | Colony-stimulating factor | Differential diagnosis | Growth factors | Immunoglobulins | Medical imaging | Psoriasis | Cytokines | Granulocyte-macrophage colony-stimulating factor | Colonies | Aquaporins | Neutrophils | CCL4 protein | Patients | Microglia | Neurological diseases | Neurology | Overexpression | Neuromyelitis | γ-Interferon | CXCL10 protein | Interferon | Chemokines | Monocyte chemoattractant protein 1
Journal Article
Journal Article
JAMA Neurology, ISSN 2168-6149, 07/2014, Volume 71, Issue 7, pp. 905 - 912
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0135458
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 1/2017, Volume 23, Issue 1, pp. 62 - 71
Journal Article
Malaria Journal, ISSN 1475-2875, 2007, Volume 6, Issue 1, pp. 147 - 147
Journal Article